Currently, Vuity remains the only FDA-approved eye drop for treating age-related blurry vision. With PresVu's launch scheduled for October, there is considerable excitement surrounding its potential.

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company ...

The FDA (Food and Drug Administration) recently approved the use of an eye drop designed to improve age-related near-vision, reports Express.co.uk. Called Vuity, the drop is applied to each eye ...

Given that these drops can be used for years, this feature particularly makes them affordable and accessible. In 2022, a similar formulation was introduced in the US under the brand name Vuity ...

The approval has been granted to Vuity (formerly AGN-190584), a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine developed by AbbVie's Allergen unit that is now an ...